Bristol-Myers Squibb Company (BMY) Earnings Yield: 6.26%
Is Bristol-Myers Squibb Company’s earnings yield high or low?
Bristol-Myers Squibb Company's earnings yield of 6.26% is 15% above its 4-year average of 5.43%, around the middle of its 4-year range (3.53%–8.21%).
As of Thursday, June 11, 2026. 9.85% above its 12-month average of 5.70%.
BMY Earnings Yield Chart
BMY Average Earnings Yield Chart
BMY Current vs Average Earnings Yield Chart
BMY Earnings Yield Metrics
EARNINGS YIELD
6.26%
EARNINGS YIELD AVG TTM
5.70%
EARNINGS YIELD AVG 3Y
6.24%
EARNINGS YIELD AVG 5Y
5.43%
EARNINGS YIELD AVG 10Y
4.48%
EARNINGS YIELD AVG 15Y
4.10%
EARNINGS YIELD AVG 20Y
5.68%
CURRENT VS TTM AVG
+9.85%
CURRENT VS 3Y AVG
+0.26%
CURRENT VS 5Y AVG
+15.19%
CURRENT VS 10Y AVG
+39.73%
CURRENT VS 15Y AVG
+52.80%
CURRENT VS 20Y AVG
+10.19%
BMY Competitors' Earnings Yield
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Bristol-Myers Squibb Company (BMY) | $116.13B | 6.26% | 5.70% | 6.24% | 5.43% |
| Vertex Pharmaceuticals Incorporated (VRTX) | $110.59B | 3.83% | 3.41% | 3.43% | 3.73% |
| Danaher Corporation (DHR) | $126.39B | 2.82% | 2.43% | 2.72% | 3.03% |
| CVS Health Corporation (CVS) | $126.70B | 2.32% | 2.92% | 5.90% | 5.70% |
| Medtronic plc (MDT) | $102.72B | 4.65% | 3.98% | 3.73% | 3.61% |
| Intuitive Surgical, Inc. (ISRG) | $144.79B | 2.00% | 1.54% | 1.36% | 1.43% |
| Elevance Health Inc. (ELV) | $86.47B | 5.81% | 7.30% | 6.27% | 5.78% |
| Pfizer Inc. (PFE) | $149.61B | 4.99% | 6.28% | 6.38% | 7.46% |
| Cigna Corporation (CI) | $77.92B | 7.97% | 7.38% | 5.81% | 6.73% |
| Abbott Laboratories (ABT) | $155.75B | 4.01% | 5.49% | 4.05% | 3.87% |
Earnings Yield vs P/E Ratio
Earnings Yield
6.26%
EPS ÷ Price
P/E Ratio
16.0
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
- It expresses earnings relative to share price as a percentage
- It can be compared with FCF yield and dividend yield
- It can be compared with bond yields because both are percentages
- It is mathematically the inverse of the P/E ratio
Bristol-Myers Squibb Company Earnings Yield Formula & Definition
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Bristol-Myers Squibb Company Earnings Yield FAQ
- What is the earnings yield for Bristol-Myers Squibb Company (BMY)?
- The earnings yield for BMY stock is 6.26%.
- Is Bristol-Myers Squibb Company's earnings yield high or low?
- Bristol-Myers Squibb Company's earnings yield of 6.26% is 15% above its 4-year average of 5.43%, around the middle of its 4-year range (3.53%–8.21%).
- What is the TTM average earnings yield for Bristol-Myers Squibb Company (BMY)?
- The TTM average earnings yield for BMY stock is 5.70%.
- What is the 3Y average earnings yield for Bristol-Myers Squibb Company (BMY)?
- The 3Y average earnings yield for BMY stock is 6.24%.
- What is the 5Y average earnings yield for Bristol-Myers Squibb Company (BMY)?
- The 5Y average earnings yield for BMY stock is 5.43%.
- What is the 10Y average earnings yield for Bristol-Myers Squibb Company (BMY)?
- The 10Y average earnings yield for BMY stock is 4.48%.
- What is the 15Y average earnings yield for Bristol-Myers Squibb Company (BMY)?
- The 15Y average earnings yield for BMY stock is 4.10%.
- What is the 20Y average earnings yield for Bristol-Myers Squibb Company (BMY)?
- The 20Y average earnings yield for BMY stock is 5.68%.
Bristol-Myers Squibb Company Earnings Yield History
| DATE | EARNINGS YIELD |
|---|---|
| 2026-06-11 | 6.26% |
| 2026-06-10 | 6.40% |
| 2026-06-09 | 6.30% |
| 2026-06-08 | 6.41% |
| 2026-06-05 | 6.22% |
| 2026-06-04 | 6.29% |
| 2026-06-03 | 6.51% |
| 2026-06-02 | 6.54% |
| 2026-06-01 | 6.48% |
| 2026-05-29 | 6.23% |
| 2026-05-28 | 6.25% |
| 2026-05-27 | 6.19% |
| 2026-05-26 | 6.13% |
| 2026-05-22 | 5.99% |
| 2026-05-21 | 5.98% |
| 2026-05-20 | 6.08% |
| 2026-05-19 | 6.11% |
| 2026-05-18 | 6.21% |
| 2026-05-15 | 6.25% |
| 2026-05-14 | 6.27% |
| 2026-05-13 | 6.31% |
| 2026-05-12 | 6.31% |
| 2026-05-11 | 6.39% |
| 2026-05-08 | 6.34% |
| 2026-05-07 | 6.33% |
| 2026-05-06 | 6.30% |
| 2026-05-05 | 6.25% |
| 2026-05-04 | 6.20% |
| 2026-05-01 | 6.12% |
| 2026-04-30 | 5.88% |
| 2026-04-29 | 5.99% |
| 2026-04-28 | 5.92% |
| 2026-04-27 | 5.97% |
| 2026-04-24 | 5.88% |
| 2026-04-23 | 5.84% |
| 2026-04-22 | 5.87% |
| 2026-04-21 | 5.81% |
| 2026-04-20 | 5.83% |
| 2026-04-17 | 5.73% |
| 2026-04-16 | 5.85% |
| 2026-04-15 | 5.96% |
| 2026-04-14 | 5.94% |
| 2026-04-13 | 5.94% |
| 2026-04-10 | 5.89% |
| 2026-04-09 | 5.80% |
| 2026-04-08 | 5.83% |
| 2026-04-07 | 5.98% |
| 2026-04-06 | 5.81% |
| 2026-04-02 | 5.79% |
| 2026-04-01 | 5.59% |
| 2026-03-31 | 5.69% |
| 2026-03-30 | 5.78% |
| 2026-03-27 | 5.89% |
| 2026-03-26 | 5.80% |
| 2026-03-25 | 5.85% |
| 2026-03-24 | 6.01% |
| 2026-03-23 | 6.05% |
| 2026-03-20 | 6.00% |
| 2026-03-19 | 5.94% |
| 2026-03-18 | 5.81% |
| 2026-03-17 | 5.78% |
| 2026-03-16 | 5.78% |
| 2026-03-13 | 5.84% |
| 2026-03-12 | 5.85% |
| 2026-03-11 | 5.75% |
| 2026-03-10 | 5.74% |
| 2026-03-09 | 5.69% |
| 2026-03-06 | 5.72% |
| 2026-03-05 | 5.68% |
| 2026-03-04 | 5.53% |
| 2026-03-03 | 5.64% |
| 2026-03-02 | 5.53% |
| 2026-02-27 | 5.53% |
| 2026-02-26 | 5.65% |
| 2026-02-25 | 5.63% |
| 2026-02-24 | 5.60% |
| 2026-02-23 | 5.63% |
| 2026-02-20 | 5.69% |
| 2026-02-19 | 5.72% |
| 2026-02-18 | 5.78% |
| 2026-02-17 | 5.72% |
| 2026-02-13 | 5.68% |
| 2026-02-12 | 5.76% |
| 2026-02-11 | 5.76% |
| 2026-02-10 | 4.86% |
| 2026-02-09 | 4.86% |
| 2026-02-06 | 4.77% |
| 2026-02-05 | 4.97% |
| 2026-02-04 | 5.13% |
| 2026-02-03 | 5.28% |
| 2026-02-02 | 5.29% |
| 2026-01-30 | 5.37% |
| 2026-01-29 | 5.44% |
| 2026-01-28 | 5.41% |
| 2026-01-27 | 5.32% |
| 2026-01-26 | 5.41% |
| 2026-01-23 | 5.41% |
| 2026-01-22 | 5.38% |
| 2026-01-21 | 5.42% |
| 2026-01-20 | 5.45% |
| 2026-01-16 | 5.35% |
| 2026-01-15 | 5.22% |
| 2026-01-14 | 5.18% |
| 2026-01-13 | 5.29% |
| 2026-01-12 | 5.30% |
| 2026-01-09 | 5.29% |
| 2026-01-08 | 5.29% |
| 2026-01-07 | 5.21% |
| 2026-01-06 | 5.43% |
| 2026-01-05 | 5.57% |
| 2026-01-02 | 5.53% |
| 2025-12-31 | 5.48% |
| 2025-12-30 | 5.45% |
| 2025-12-29 | 5.46% |
| 2025-12-26 | 5.41% |
| 2025-12-24 | 5.40% |
| 2025-12-23 | 5.44% |
| 2025-12-22 | 5.41% |
| 2025-12-19 | 5.45% |
| 2025-12-18 | 5.54% |
| 2025-12-17 | 5.52% |
| 2025-12-16 | 5.45% |
| 2025-12-15 | 5.44% |
| 2025-12-12 | 5.64% |
| 2025-12-11 | 5.77% |
| 2025-12-10 | 5.77% |
| 2025-12-09 | 5.83% |
| 2025-12-08 | 5.72% |
| 2025-12-05 | 5.67% |
| 2025-12-04 | 5.69% |
| 2025-12-03 | 5.80% |
| 2025-12-02 | 6.12% |
| 2025-12-01 | 6.01% |
| 2025-11-28 | 6.01% |
| 2025-11-26 | 6.00% |
| 2025-11-25 | 6.02% |
| 2025-11-24 | 6.19% |
| 2025-11-21 | 6.39% |
| 2025-11-20 | 6.44% |
| 2025-11-19 | 6.46% |
| 2025-11-18 | 6.28% |
| 2025-11-17 | 6.31% |
| 2025-11-14 | 6.33% |
| 2025-11-13 | 6.08% |
| 2025-11-12 | 6.02% |
| 2025-11-11 | 6.06% |
| 2025-11-10 | 6.25% |
| 2025-11-07 | 6.33% |
| 2025-11-06 | 6.34% |
| 2025-11-05 | 6.36% |
| 2025-11-04 | 6.48% |
| 2025-11-03 | 6.42% |
| 2025-10-31 | 6.41% |
| 2025-10-30 | 6.48% |
| 2025-10-29 | 5.81% |
| 2025-10-28 | 5.78% |
| 2025-10-27 | 5.70% |
| 2025-10-24 | 5.65% |
| 2025-10-23 | 5.65% |
| 2025-10-22 | 5.58% |
| 2025-10-21 | 5.56% |
| 2025-10-20 | 5.68% |
| 2025-10-17 | 5.67% |
| 2025-10-16 | 5.70% |
| 2025-10-15 | 5.68% |
| 2025-10-14 | 5.65% |
| 2025-10-13 | 5.69% |
| 2025-10-10 | 5.63% |
| 2025-10-09 | 5.54% |
| 2025-10-08 | 5.56% |
| 2025-10-07 | 5.54% |
| 2025-10-06 | 5.48% |
| 2025-10-03 | 5.45% |
| 2025-10-02 | 5.41% |
| 2025-10-01 | 5.22% |
| 2025-09-30 | 5.49% |
| 2025-09-29 | 5.61% |
| 2025-09-26 | 5.61% |
| 2025-09-25 | 5.70% |
| 2025-09-24 | 5.61% |
| 2025-09-23 | 5.51% |
| 2025-09-22 | 5.50% |
| 2025-09-19 | 5.50% |
| 2025-09-18 | 5.43% |
| 2025-09-17 | 5.36% |
| 2025-09-16 | 5.34% |
| 2025-09-15 | 5.34% |
| 2025-09-12 | 5.36% |
| 2025-09-11 | 5.21% |
| 2025-09-10 | 5.25% |
| 2025-09-09 | 5.24% |
| 2025-09-08 | 5.30% |
| 2025-09-05 | 5.25% |
| 2025-09-04 | 5.30% |
| 2025-09-03 | 5.21% |
| 2025-09-02 | 5.22% |
| 2025-08-29 | 5.25% |
| 2025-08-28 | 5.28% |
| 2025-08-27 | 5.20% |
| 2025-08-26 | 5.24% |
| 2025-08-25 | 5.25% |
| 2025-08-22 | 5.17% |
| 2025-08-21 | 5.11% |
| 2025-08-20 | 5.13% |
| 2025-08-19 | 5.12% |
| 2025-08-18 | 5.14% |
| 2025-08-15 | 5.11% |
| 2025-08-14 | 5.18% |
| 2025-08-13 | 5.17% |
| 2025-08-12 | 5.32% |
| 2025-08-11 | 5.39% |
| 2025-08-08 | 5.39% |
| 2025-08-07 | 5.46% |
| 2025-08-06 | 5.52% |
| 2025-08-05 | 5.40% |
| 2025-08-04 | 5.45% |
| 2025-08-01 | 5.60% |
| 2025-07-31 | 5.71% |
| 2025-07-30 | 5.80% |
| 2025-07-29 | 5.69% |
| 2025-07-28 | 5.61% |
| 2025-07-25 | 5.50% |
| 2025-07-24 | 5.45% |
| 2025-07-23 | 5.44% |
| 2025-07-22 | 5.55% |
| 2025-07-21 | 5.71% |
| 2025-07-18 | 5.63% |
| 2025-07-17 | 5.55% |
| 2025-07-16 | 5.65% |
| 2025-07-15 | 5.74% |
| 2025-07-14 | 5.63% |
| 2025-07-11 | 5.69% |
| 2025-07-10 | 5.49% |
| 2025-07-09 | 5.59% |
| 2025-07-08 | 5.67% |
| 2025-07-07 | 5.73% |
| 2025-07-03 | 5.68% |
| 2025-07-02 | 5.60% |
| 2025-07-01 | 5.61% |
| 2025-06-30 | 5.76% |
| 2025-06-27 | 5.75% |
| 2025-06-26 | 5.71% |
| 2025-06-25 | 5.71% |
| 2025-06-24 | 5.67% |
| 2025-06-23 | 5.68% |
| 2025-06-20 | 5.69% |
| 2025-06-18 | 5.69% |
| 2025-06-17 | 5.64% |
| 2025-06-16 | 5.48% |
| 2025-06-13 | 5.36% |
| 2025-06-12 | 5.26% |
| 2025-06-11 | 5.31% |
| 2025-06-10 | 5.33% |
| 2025-06-09 | 5.44% |
| 2025-06-06 | 5.51% |
| 2025-06-05 | 5.57% |
| 2025-06-04 | 5.56% |
| 2025-06-03 | 5.54% |
| 2025-06-02 | 5.46% |
| 2025-05-30 | 5.52% |
Showing the most recent 260 of 4,402 data points. The chart above shows the full history.
Related Metrics
About Bristol-Myers Squibb Company
Bristol-Myers Squibb Company operates as a global biopharmaceutical entity, actively involved in the research, development, licensing, production, and worldwide commercialization of its medicinal portfolio. The company's therapeutic areas span hematology, oncology, cardiovascular health, immunology, fibrotic conditions, neuroscience, and infectious diseases like COVID-19. Its significant pharmaceutical offerings include Revlimid, an oral immunomodulatory agent for multiple myeloma, and Eliquis, an oral anticoagulant crucial for reducing stroke risk and systemic embolism in non-valvular atrial fibrillation, as well as treating deep vein thrombosis and pulmonary embolism. The portfolio also features Opdivo, utilized across various anti-cancer indications; Pomalyst/Imnovid, prescribed for multiple myeloma patients; and Orencia, targeting active rheumatoid arthritis and psoriatic arthritis in adults. Other key therapies are Sprycel, employed in the management of Philadelphia chromosome-positive chronic myeloid leukemia; Yervoy, indicated for patients with unresectable or metastatic melanoma; and Abraxane, a protein-bound chemotherapy formulation. Furthermore, Bristol-Myers Squibb offers Reblozyl, addressing anemia in adult patients with beta thalassemia; Empliciti, another treatment option for multiple myeloma; and Zeposia, designed to treat relapsing forms of multiple sclerosis. Revolutionary treatments like Breyanzi, a CD19-directed genetically modified autologous T cell immunotherapy for adult patients battling relapsed or refractory large B-cell lymphoma, are also part of its lineup. Completing its product range are Inrebic, an oral kinase inhibitor specifically for adult myelofibrosis, and Onureg, used in the treatment of adult patients with acute myeloid leukemia (AML). Bristol-Myers Squibb distributes its pharmaceutical products through a diverse network encompassing wholesalers, distributors, pharmacies, retail outlets, hospitals, clinics, and governmental organizations. Founded in 1887 and formerly known as Bristol-Myers Company, the firm maintains its headquarters in New York, New York.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Christopher S. Boerner